We recently reported that A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, is able to inhibit the replication of influenza A virus and porcine epidemic diarrhea virus by targeting JAK1 and JAK2 [57,58]. This evidence concerns the gene JAK1 and rheumatoid arthritis.